ABSTRACT The vascular endothelial injury occurs in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections, but the mechanisms are poorly understood. We sought to determine the frequency and type of cytokine elevations and their relationship to endothelial injury induced by plasma from patients with SARS-CoV-2 versus controls. Plasma from eight consecutively enrolled patients hospitalized with acute SARS-CoV-2 infection was compared to controls. Endothelial cell (EC) barrier integrity was evaluated using ECIS (electric cell-substrate impedance sensing) on human lung microvascular EC. Plasma from all SARS-CoV-2 but none from controls decreased transendothelial resistance to a greater degree than that produced by tumor necrosis factor-alpha (TNF-α), the positive control for the assay. Thrombin, angiopoietin 2 (Ang2), and vascular endothelial growth factor (VEGF), complement factor C3a and C5a, and spike protein increased endothelial permeability, but to a lesser extent and a shorter duration when compared to SARS-CoV-2 plasma. Analysis of Ang2, VEGF, and 15 cytokines measured in plasma revealed striking patient-to-patient variability within the SARS-CoV-2 patients. Pretreatment with thrombin inhibitors, single, or combinations of neutralizing antibodies against cytokines, Ca3 and C5a receptor antagonists, or with ACE2 antibody failed to lessen the SARS-CoV-2 plasma-induced EC permeability. The EC barrier destructive effects of plasma from patients with SARS-CoV-2 were susceptible to heat inactivation. Plasma from patients hospitalized with acute SARS-CoV-2 infection uniformly disrupts lung microvascular integrity. No predicted single, or set of, cytokine(s) accounted for the enhanced vascular permeability, although the factor(s) were heat-labile. A still unidentified but potent circulating factor(s) appears to cause the EC disruption in SARS-CoV-2 infected patients. IMPORTANCE Lung vascular endothelial injury in SARS-CoV-2 patients is one of the most important causes of morbidity and mortality and has been linked to more severe complications including acute respiratory distress syndrome (ARDS) and subsequent death due to multiorgan failure. We have demonstrated that in eight consecutive patients with SARS-CoV-2, who were not selected for evidence of endothelial injury, the diluted plasma-induced intense lung microvascular damage, in vitro . Known endothelial barrier-disruptive agents and proposed mediators of increased endothelial permeability in SARS-CoV-2, induced changes in permeability that were smaller in magnitude and shorter in duration than plasma from patients with SARS-CoV-2. The effect on endothelial cell permeability of plasma from patients with SARS-CoV-2 was heat-labile. The main plasma factor that causes the increased endothelial permeability remains to be identified. Our study provides a possible approach for future studies to understand the underlying mechanisms leading to vascular injury in SARS-CoV-2 infections.
【저자키워드】 SARS-CoV-2, Neutralizing antibodies, cytokine, Spike protein, ACE-2 receptor, heat inactivation, plasma, endothelial injury, barrier dysfunction, endothelial permeability, complements factors, SARS-CoV-2 plasma, antiinflammatory cytokines, proinflammatory cytokines, 【초록키워드】 neutralizing antibody, Tumor, ARDS, coronavirus, Cytokines, acute respiratory distress syndrome, Neutralizing antibodies, SARS-COV-2 infection, lung, complement, cytokine, vascular permeability, in vitro, severe acute respiratory syndrome Coronavirus, inhibitors, Spike protein, C5a, angiopoietin, infections, tumor necrosis factor, heat inactivation, human lung, morbidity, Control, death, plasma, morbidity and mortality, endothelial injury, receptor, respiratory, SARS-CoV-2 infections, patients, mechanism, TNF-α, acute respiratory distress, SARS-CoV-2 patients, Endothelial cell, Evidence, Combination, Frequency, permeability, evidence of, thrombin, respiratory distress, tumor necrosis, receptor antagonists, vascular endothelial growth factor, Vascular injury, endothelial, acute respiratory syndrome, tumor necrosis factor-alpha, Vascular, acute respiratory syndrome coronavirus, acute respiratory syndrome coronavirus 2, SARS-CoV-2 infected patients, Variability, multiorgan failure, syndrome, Elevation, VEGF, antagonists, acute SARS-CoV-2 infection, circulating, severe complications, growth factor, positive control, Microvascular damage, ACE2 antibody, labile, Effect, approach, susceptible, controls, Cell, greater, enrolled, selected, produced, predicted, subsequent, evaluated, eight, accounted, appear, provide, determine, changes in, occur, demonstrated, magnitude, cause, disrupt, severe complication, C3a, consecutive patient, patients hospitalized, patients with SARS-CoV-2, SARS-CoV-2 patient, the SARS-CoV-2, 【제목키워드】 cytokine, pulmonary, Level,